InvestorsHub Logo

joboggi

05/11/17 10:46 AM

#126273 RE: JPetroInc #126270

In the event that creditors and certain other parties decline to participate in the planned restructuring of liabilities to be developed by Amarantus' management under the supervision of the Board, and to execute such releases as may be required in connection with such restructuring, SeD Biomedical reserves the right to terminate the LOI.